Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 3.15B |
| Enterprise Value | 3.11B |
| P/E Ratio | 63.85 |
| PEG Ratio | -1.36 |
| Price/Sales Ratio | 2.68 |
| Price/Book Ratio | 1.37 |
| Enterprise/Revenue | 2.57 |
| Enterprise/EBITDA | 25.87 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.04 |
| Operating Margin | 0.07 |
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
| Revenue | 844.54M |
| Revenue/Share | 4.39 |
| Gross Profit | 220.87M |
| EBITDA | 158.44M |
| Net Income | 62.16M |
| Diluted EPS | 0.35 |
| Total Cash | 588.82M |
| Total Cash/Share | 3.16 |
| Total Debt | 436.57M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 3.64 |
| Book Value Per Share | 8.68 |
| 52-Week Change | -46.23 |
| 52-Week High | 22 |
| 52-Week Low | 9.94 |
| Moving Average 50 Days | 12.58 |
| Moving Average 200 Days | 14.43 |
| Average Volume | 6.8M |
| Shares Outstanding | 189.03M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 0.86 |
| Payout Ratio | 0.8 |
| Last Split Factor | 7:5 |
| Last Split Date | June 08, 2020 |